291 related articles for article (PubMed ID: 22230369)
21. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants.
Burow ME; Weldon CB; Tang Y; Navar GL; Krajewski S; Reed JC; Hammond TG; Clejan S; Beckman BS
Cancer Res; 1998 Nov; 58(21):4940-6. PubMed ID: 9810003
[TBL] [Abstract][Full Text] [Related]
22. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells.
Crawford KW; Bittman R; Chun J; Byun HS; Bowen WD
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1017-23. PubMed ID: 14682383
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species.
Chan SY; Hilchie AL; Brown MG; Anderson R; Hoskin DW
Exp Mol Pathol; 2007 Feb; 82(1):1-11. PubMed ID: 16624283
[TBL] [Abstract][Full Text] [Related]
24. Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism.
Mullen TD; Spassieva S; Jenkins RW; Kitatani K; Bielawski J; Hannun YA; Obeid LM
J Lipid Res; 2011 Jan; 52(1):68-77. PubMed ID: 20940143
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis occurs via the ceramide recycling pathway in human HaCaT keratinocytes.
Takeda S; Mitsutake S; Tsuji K; Igarashi Y
J Biochem; 2006 Feb; 139(2):255-62. PubMed ID: 16452313
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.
Ahn EH; Schroeder JJ
Anticancer Res; 2010 Jul; 30(7):2881-4. PubMed ID: 20683027
[TBL] [Abstract][Full Text] [Related]
27. 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length.
Mizutani Y; Kihara A; Chiba H; Tojo H; Igarashi Y
J Lipid Res; 2008 Nov; 49(11):2356-64. PubMed ID: 18541923
[TBL] [Abstract][Full Text] [Related]
28. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma.
Stover TC; Sharma A; Robertson GP; Kester M
Clin Cancer Res; 2005 May; 11(9):3465-74. PubMed ID: 15867249
[TBL] [Abstract][Full Text] [Related]
29. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development.
Tran MA; Smith CD; Kester M; Robertson GP
Clin Cancer Res; 2008 Jun; 14(11):3571-81. PubMed ID: 18519791
[TBL] [Abstract][Full Text] [Related]
30. Ceramide glycosylation potentiates cellular multidrug resistance.
Liu YY; Han TY; Giuliano AE; Cabot MC
FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
[TBL] [Abstract][Full Text] [Related]
31. AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells.
Jin J; Mullen TD; Hou Q; Bielawski J; Bielawska A; Zhang X; Obeid LM; Hannun YA; Hsu YT
J Lipid Res; 2009 Dec; 50(12):2389-97. PubMed ID: 19528633
[TBL] [Abstract][Full Text] [Related]
32. Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer.
Kim SJ; Seo I; Kim MH; Park JW; Kim S; Park WJ
Lipids Health Dis; 2023 Oct; 22(1):183. PubMed ID: 37885013
[TBL] [Abstract][Full Text] [Related]
33. Ceramide biosynthesis in keratinocyte and its role in skin function.
Mizutani Y; Mitsutake S; Tsuji K; Kihara A; Igarashi Y
Biochimie; 2009 Jun; 91(6):784-90. PubMed ID: 19364519
[TBL] [Abstract][Full Text] [Related]
34. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
Park JW; Park WJ; Futerman AH
Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/Lass2.
Becker I; Wang-Eckhardt L; Yaghootfam A; Gieselmann V; Eckhardt M
Histochem Cell Biol; 2008 Feb; 129(2):233-41. PubMed ID: 17901973
[TBL] [Abstract][Full Text] [Related]
37. C
Chang WT; Wu CY; Lin YC; Wu MT; Su KL; Yuan SS; Wang HD; Fong Y; Lin YH; Chiu CC
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480728
[TBL] [Abstract][Full Text] [Related]
38. Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression.
Erez-Roman R; Pienik R; Futerman AH
Biochem Biophys Res Commun; 2010 Jan; 391(1):219-23. PubMed ID: 19912991
[TBL] [Abstract][Full Text] [Related]
39. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
Furlong SJ; Ridgway ND; Hoskin DW
Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
[TBL] [Abstract][Full Text] [Related]
40. Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells.
Kim SW; Kim HJ; Chun YJ; Kim MY
J Toxicol Environ Health A; 2010; 73(21-22):1465-76. PubMed ID: 20954073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
